Published in Cancer on April 01, 1965
Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A (1981) 11.92
Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A (1985) 8.53
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol (1992) 5.85
Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 5.80
Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 4.37
Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A (1981) 4.34
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A (1989) 4.22
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A (1975) 4.21
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J (1990) 3.21
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest (2008) 2.68
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc Natl Acad Sci U S A (1991) 2.67
Human homologue of murine T200 glycoprotein. J Exp Med (1980) 2.57
The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J Virol (1992) 2.49
Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci U S A (1982) 2.42
Role of Vif in human immunodeficiency virus type 1 reverse transcription. J Virol (1996) 2.35
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J Virol (2008) 2.27
Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J Virol (1988) 2.24
Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol (1995) 2.19
Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes. Proc Natl Acad Sci U S A (1982) 2.06
Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: relation to primate retroviruses. J Virol (1989) 2.05
Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proc Natl Acad Sci U S A (1983) 2.04
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol (1990) 2.03
Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J (1994) 1.94
Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci U S A (1994) 1.94
Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Mol Cell Biol (1985) 1.92
Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol (1987) 1.84
Chemical mutagenesis at the phosphoribosyltransferase locus in cultured human lymphoblasts. Proc Natl Acad Sci U S A (1972) 1.83
Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J Exp Med (1991) 1.78
Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. J Virol (1991) 1.73
Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med (1984) 1.68
The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits. J Cell Biol (1992) 1.67
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med (1988) 1.67
HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med (1998) 1.66
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J (1993) 1.59
Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J Virol (1997) 1.59
Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem (2007) 1.58
Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. J Virol (1993) 1.57
Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine. J Clin Microbiol (1995) 1.57
National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing. Pediatr Blood Cancer (2010) 1.47
Biological and biochemical studies of African green monkey lymphotropic papovavirus. J Virol (1982) 1.46
A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. Virology (2008) 1.45
Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells. J Virol (2009) 1.45
Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4). J Virol (1977) 1.44
The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol (1997) 1.42
Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. J Virol (1994) 1.42
Lineage-restricted expression of homeobox-containing genes in human hematopoietic cell lines. Proc Natl Acad Sci U S A (1989) 1.40
Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus. J Clin Microbiol (1987) 1.40
Use of an indicator sequence of human DNA to study DNA damage by methylbis(2-chloroethyl)amine. Proc Natl Acad Sci U S A (1980) 1.40
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am J Pathol (1994) 1.39
Membranes from T and B lymphocytes have different patterns of tyrosine phosphorylation. Proc Natl Acad Sci U S A (1984) 1.38
Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. Yale J Biol Med (1971) 1.38
HEX: a novel homeobox gene expressed during haematopoiesis and conserved between mouse and human. Nucleic Acids Res (1993) 1.38
Detection, characterization and regulation of antisense transcripts in HIV-1. Retrovirology (2007) 1.35
Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n. PLoS Pathog (2012) 1.29
Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Proc Natl Acad Sci U S A (1981) 1.26
Silencing of Agamma-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site. Mol Cell Biol (2008) 1.25
Predicting adverse drug reactions using publicly available PubChem BioAssay data. Clin Pharmacol Ther (2011) 1.24
vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J Virol (1996) 1.22
Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells. J Virol (1982) 1.21
Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. J Clin Invest (1982) 1.21
Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1. Antimicrob Agents Chemother (1987) 1.19
Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol (1990) 1.19
Productive infection of cultured human lymphoid cells by adenovirus. J Virol (1987) 1.17
Affinity for the nuclear compartment and expression during cell differentiation implicate phosphorylated Groucho/TLE1 forms of higher molecular mass in nuclear functions. Biochem J (1996) 1.17
Different pathways of human T-cell activation revealed by PHA-P and PHA-M. Immunology (1986) 1.16
The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus. J Virol (1993) 1.14
Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Antimicrob Agents Chemother (1990) 1.13
Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1987) 1.13
Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics (2003) 1.13
Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis (2004) 1.13
Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane. Proc Natl Acad Sci U S A (1998) 1.12
Enhancement of human natural cell-mediated cytotoxicity by interferon. Br J Cancer (1980) 1.11
Activation of latent HIV using drug-loaded nanoparticles. PLoS One (2011) 1.10
Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc Natl Acad Sci U S A (1993) 1.10
Screening and diagnostic performance of enzyme immunoassay for antibody to lymphadenopathy-associated virus. J Clin Microbiol (1987) 1.10
Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer (2009) 1.08
Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database. Antimicrob Agents Chemother (2010) 1.08
Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int (2007) 1.08
Bone marrow-derived lymphoid cell lines from patients with agammaglobulinemia. J Clin Invest (1978) 1.07
Renalase prevents AKI independent of amine oxidase activity. J Am Soc Nephrol (2014) 1.07
Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates. Bioorg Med Chem (2006) 1.06
On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc Natl Acad Sci U S A (1992) 1.05
Natural antibodies in sera from healthy humans to antigens on surfaces of type C RNA viruses and cells from primates. Proc Natl Acad Sci U S A (1976) 1.05
Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity. Proc Natl Acad Sci U S A (1982) 1.04
Thymidylate synthetase purified to homogeneity from human leukemic cells. Proc Natl Acad Sci U S A (1979) 1.04
Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates. J Med Chem (2005) 1.03
Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells. J Clin Invest (1978) 1.03
Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol (1994) 1.03
Natural species-restricted attachment of human and murine T lymphocytes to various cells. Proc Natl Acad Sci U S A (1978) 1.00
CNA.42, a new monoclonal antibody directed against a fixative-resistant antigen of follicular dendritic reticulum cells. Am J Pathol (1997) 1.00
Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2. Antimicrob Agents Chemother (2007) 1.00
Comparative study of alkaline phosphatase activity in lymphocytes, mitogen-induced blasts, lymphoblastoid cell lines, acute myeloid leukemia, and chronic lymphatic leukemia cells. Proc Natl Acad Sci U S A (1976) 0.99
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol (1992) 0.99
Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS One (2013) 0.99
Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts. J Cell Biol (1975) 0.98
Electron microscope studies of the formation of nodes of Ranvier in mouse sciatic nerves. J Biophys Biochem Cytol (1957) 4.36
Neuroblastoma sympatheticum; a study and report of 217 cases. Pediatrics (1959) 3.93
Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var. stellatoidea. J Infect Dis (1950) 2.89
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med (1948) 2.81
Potentiation of x-ray effects by actinomycin D. Radiology (1959) 2.53
Isolation and serial propagation of malignant and normal cells in semi-defined media. Origins of CCRF cell lines. Cancer Res (1960) 2.44
Cytotoxicity in human cell cultures as a primary screen for the detection of anti-tumor agents. Cancer Res (1958) 1.84
Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore) (1958) 1.80
Clinical studies on actinomycin D with special reference to Wilms' tumor in children. Ann N Y Acad Sci (1960) 1.77
Advances in chemotherapy of cancer in man. Adv Cancer Res (1956) 1.65
Duplications of the alimentary tract. Pediatrics (1952) 1.60
A comparison of nodes of Ranvier in sciatic nerves with node-like structures in optic nerves of the mouse. J Biophys Biochem Cytol (1960) 1.41
Lipogranulomatosis; a new lipo-glycoprotein storage disease. J Mt Sinai Hosp N Y (1958) 1.40
Assessment of potential malignancy of cultured cells: further observations on the differentiation of "normal" and "neoplastic" cells maintained in vitro by hetero-transplantation in Syrian hamsters. Natl Cancer Inst Monogr (1962) 1.37
Candida infections in children with neoplastic disease; influence of therapy with antibiotics and steroid hormones. Pediatrics (1956) 1.24
Atresia of the mitral valve. Arch Surg (1961) 1.18
Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro. Cancer Res (1961) 1.17
Studies on the biology of Cryptococcus. IV. Isolation of a highly polymerized polysaccharide from encapsulated strains. J Infect Dis (1952) 1.15
Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood (1949) 1.11
The effect of long-term antibiotic therapy in patients with cystic fibrosis of the pancreas. Antibiot Annu (1959) 1.08
The cytotoxic action of carcinolytic agents in tissue culture. Am J Med (1956) 1.06
CELL CULTURE AND CANCER CHEMOTHERAPY. Adv Chemother (1964) 0.98
Hemostasis in thrombocytopenic bleeding following infusion of stored, frozen platelets. Blood (1956) 0.98
THE SPIRAL CONFIGURATION OF MYELIN LAMELLAE. J Ultrastruct Res (1964) 0.97
Use of cortisone in erythema nodosum. AMA Arch Intern Med (1951) 0.95
The preparation and clinical administration of lyophilized platelet material to children with acute leukemia and aplastic anemia. J Pediatr (1956) 0.94
Chemical and biological studies on 1,2-dihydro-s-triazines. XI. Inhibition of root growth and its reversal by citrovorum factor. Science (1955) 0.94
VINCRISTINE IN THE TREATMENT OF ACUTE LEUKEMIA IN CHILDREN. Cancer (1963) 0.94
Effects of spermine on mammalian cells. Arch Biochem Biophys (1961) 0.93
The effect of therapy on the life history and biologic behavior of leukemia. Proc Inst Med Chic (1951) 0.93
Transfusions of fresh platelet concentrates to patients with secondary thrombocytopenia. N Engl J Med (1963) 0.92
BOTRYOMYCOSIS, A COMPLICATION CYSTIC FIBROSIS. REPORT OF 7 CASES. J Pediatr (1964) 0.92
Enhancement of Candida infection: differential distribution of renal lesions in mice treated with aureomycin. J Infect Dis (1956) 0.92
A lipid metabolic disorder: disseminated lipogranulomatosis; a syndrome with similarity to, and important difference from, Niemann-Pick and Hand-Schüller-Christian disease. AMA Am J Dis Child (1952) 0.90
Summary of experience with 6-mercaptopurine. Ann N Y Acad Sci (1954) 0.87
Synthesis of citrovorum factor by Leuconostoc citrovorum; potentiation by ascorbic acid. J Bacteriol (1953) 0.86
LOSS OF NEOPLASTIC PROPERTIES IN VITRO. I. OBSERVATIONS WITH S-180 CELL LINES. Cancer Res (1964) 0.86
Biological studies of actinomycin D. Ann N Y Acad Sci (1960) 0.84
CYTOCHEMICAL OBSERVATIONS ON THE NUCLEOLUS-RIBOSOME SYSTEM. EFFECTS OF ACTINOMYCIN D AND NITROGEN MUSTARD. Exp Cell Res (1963) 0.84
MODIFICATION OF THE IMMUNE RESPONSE OF MICE TO SKIN HOMOGRAFTS AND HETEROGRAFTS BY EHRLICH ASCITES CARCINOMA. Cancer Res (1964) 0.83
THE APPLICATION OF QUANTITATIVE CYTOCHEMICAL TECHNIQUES TO THE STUDY OF INDIVIDUAL MAMMALIAN CHROMOSOMES. Exp Cell Res (1963) 0.83
Studies on the streptococci (entercococci) of Lancefield group D; recovery of Lancefield group D streptococoi from antemortem and postmortem cultures from infants and young children. Am J Dis Child (1945) 0.82
Chemical and biological studies on 1, 2-dihydro-s-triazines. VIII. Activity in nicotinic acid, riboflavin and thiamine systems. Antonie Van Leeuwenhoek (1955) 0.82
Sustained propagation of sarcoma of 180 in tissue culture. Proc Soc Exp Biol Med (1956) 0.81
Differentiation of normal and neoplastic cells maintained in tissue culture by implantation into normal hamsters. Proc Soc Exp Biol Med (1957) 0.80
Chemical and biological studies on 1,2-dihydro-s-triazines. VI. Development of resistance by Streptococcus faecalis No. 8043. Proc Soc Exp Biol Med (1954) 0.79
CYTOCHEMICAL DIFFERENCES BETWEEN MAMMALIAN CELL LINES OF NORMAL AND NEOPLASTIC ORIGINS. CORRELATION WITH HETEROTRANSPLANT- ABILITY IN SYRIAN HAMSTERS. Exp Cell Res (1963) 0.79
Experimental clinical cancer chemotherapy. Prospects for the years ahead. Cancer Chemother Rep (1962) 0.79
Nicotinic acid requirements of Candida pseudotropicalis. J Bacteriol (1961) 0.79
The effects of varying concentrations of human platelets and their stored derivatives on the recalcification time of plasma. Blood (1956) 0.79
Clinical pathological conference: The Children's Medical Center, Boston, Mass. J Pediatr (1958) 0.78
Studies on the biology of Cryptococcus. VI. Amino acid composition of the somatic proteins of Cryptococcus neoformans. J Infect Dis (1956) 0.78
TRANSFUSION OF FRESH CONCENTRATED PLATELETS TO CHILDREN WITH ACUTE LEUKEMIA. J Pediatr (1965) 0.78
Serologic types of hemolytic streptococci in scarlet fever in Massachusetts. N Engl J Med (1945) 0.77
A comparative study of the use of microorganisms in the screening of potential antitumor agents. Ann N Y Acad Sci (1958) 0.77
Chemotherapeutic studies of tumors, including leukemia, in children. Am J Dis Child (1950) 0.76
Studies on mortality in chick embryos resulting from implantation of whole blood and blood fractions from patients and animals with neoplastic disease. Proc Natl Acad Sci U S A (1962) 0.75
The treatment of acute leukemia. J Chronic Dis (1956) 0.75
Effects of soybean phosphatides on the hemorrhagic tendency due to thrombocytopenia. J Clin Invest (1962) 0.75
The future of the cancer chemotherapy national program. Natl Cancer Inst Monogr (1960) 0.75
Clinical pathological conference. The Children's Hospital Medical Center, Boston, Mass. J Pediatr (1963) 0.75
THE CLOSED-CHEST METHOD OF CARDIOPULMONARY RESUSCITATION--REVISED STATEMENT. Circulation (1965) 0.75
Clinical pathological conference. The Children's Hospital Medical Center, Boston, Mass. J Pediatr (1963) 0.75
New developments in chemotherapy and the care of the cancer patient. Am J Public Health Nations Health (1961) 0.75
MANAGEMENT OF THE ACUTE LEUKEMIA PATIENT AND FAMILY. CA Cancer J Clin (1965) 0.75
Further studies on the growth of homologous and heterologous lymphoma and leukemia transplants in Syrian hamsters. Acta Unio Int Contra Cancrum (1960) 0.75
THE CHILDREN'S HOSPITAL MEDICAL CENTER, BOSTON, MASS. J Pediatr (1965) 0.75
I. S. RAVDIN--CIVILIAN ACTIVITIES AT THE NATIONAL LEVEL. Surgery (1964) 0.75
Submerged growth of tubercle bacilli from pathologic material in Dubos' medium. Proc Soc Exp Biol Med (1946) 0.75
Effects of Escherichia coli endotoxin on rat platelets. Am J Physiol (1962) 0.75
Further observations on the occurrence of streptococci other than group A in human infection. J Bacteriol (1947) 0.75
CLINICAL PATHOLOGICAL CONFERENCE; THE CHILDREN'S HOSPITAL MEDICAL CENTER, BOSTON, MASS. J Pediatr (1963) 0.75
Current clinical and experimental studies in cancer chemotherapy. Cancer Chemother Rep (1961) 0.75
A note on the serologic classification of streptococci isolated from subacute bacterial endocarditis. Am Heart J (1945) 0.75
The in vitro streptomycin sensitivity of Salmonella isolated from cases and carriers in Massachusetts. J Bacteriol (1947) 0.75
CLINICAL PATHOLOGICAL CONFERENCE. THE CHILDREN'S HOSPITAL MEDICAL CENTER, BOSTON, MASS. J Pediatr (1964) 0.75
Derivatives of 2,4-diaminopyrimidine as growth inhibitors. Acta Unio Int Contra Cancrum (1960) 0.75
The Children's Hospital Medical Center, Boston, Mass. J Pediatr (1963) 0.75
Serologic types of bacteria as an epidemiologic principle. Am J Med Sci (1946) 0.75
THE CHILDREN'S HOSPITAL MEDICAL CENTER, BOSTON, MASS. J Pediatr (1964) 0.75
Survival of total-body x-irradiated mice after delayed infusions of isologous bone marrow. Radiat Res (1960) 0.75
CLINICAL PATHOLOGICAL CONFERENCE: THE CHILDREN'S HOSPITAL MEDICAL CENTER, BOSTON, MASS. J Pediatr (1963) 0.75
CYTOCHEMICAL DIFFERENCES BETWEEN NORMAL AND NEOPLASTIC CELL POPULATIONS. Acta Unio Int Contra Cancrum (1964) 0.75
[Discussion of a case of tetralogy of Fallot]. Pediatr Panam (1963) 0.75
CLINICAL PATHOLOGICAL CONFERENCE: THE CHILDREN'S HOSPITAL MEDICAL CENTER, BOSTON, MASS. J Pediatr (1965) 0.75
REACTION OF 6-CHLORO-2-CHLOROMETHYL-4-PHENYLQUINAZOLINE 3-OXIDE WITH DIMETHYLAMINE. J Med Chem (1964) 0.75
[Osteogenesis imperfecta]. Pediatr Panam (1963) 0.75
Clinical pathological conference: The Children's Hospital Medical Center, Boston, Mass. J Pediatr (1963) 0.75
Cytochemical study of nucleolus-ribosome system in populations of normal and neoplastic cells. Exp Cell Res (1962) 0.75
Streptomycin therapy in 52 cases of bacterial infection. N Engl J Med (1947) 0.75
[Infantile dermatomyositis]. Pediatr Panam (1963) 0.75
Scarlet fever; an epidemiologic and bacteriologic study of cases occurring in a small community. N Engl J Med (1946) 0.75
PREPARATION AND GROWTH-INHIBITORY PROPERTIES OF NEW POLYCYCLIC 2,4-DIAMINOPYRIMIDINES. Acta Unio Int Contra Cancrum (1964) 0.75
The epidemiologic significance of amplitudes of seasonal fluctuation in infectious diseases. Am J Med Sci (1946) 0.75
Clinical pathological conference: the Children's Medical Center Boston, Mass. J Pediatr (1959) 0.75